Anixa Biosciences (ANIX) Operating Margin (QoQ) (2010 - 2018)
Anixa Biosciences (ANIX) Operating Margin (QoQ) (2010 - 2018) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.84 Bn | 131.99 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.48 Bn | 78.49 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.47 Bn | 60.29 Bn | 1.37 Bn |
| 4 | Moderna | 60.15 Bn | 55.01 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.22 Bn | 37.12 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.67 Bn | 28.36 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.54 Bn | 10.14 Bn | 668.28 Mn |
| 8 | Insmed | 27.58 Bn | 26.42 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.22 Bn | 26.38 Bn | - |
| 10 | Anixa Biosciences | 124.80 Mn | 124.80 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 31, 2018 | -135,963.00 |
| Oct 31, 2016 | 51,823.00 |
| Jul 31, 2015 | 696,377.00 |
| Apr 30, 2015 | -857,517.00 |
| Jan 31, 2015 | 15,600.00 |
| Oct 31, 2014 | -10,034.00 |
| Oct 31, 2012 | -49.28 Mn |
| Jul 31, 2012 | 9,613.00 |
| Apr 30, 2012 | -15,649.00 |
| Jan 31, 2012 | 2,676.00 |
| Oct 31, 2011 | 4,388.00 |
| Jul 31, 2011 | 121,324.00 |
| Apr 30, 2011 | 751,812.00 |
| Jan 31, 2011 | -863,744.00 |
| Oct 31, 2010 | 182,689.00 |